Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: The Effect of Inspiratory Muscle Training on Balance and Postural Control in Multiple Sclerosis Patients [NA]
This trial update notes the completion of a study evaluating inspiratory muscle training on balance and postural control in individuals with…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
Clinical trial registry update for the PRISMA pregnancy registry, collecting data on infants and maternal serum/milk analysis to assess expo…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Illuminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized Rehabilitation [Phase 2]
This ClinicalTrials.gov entry outlines a Phase 2 study investigating early and specialized rehabilitation strategies for relapses in multipl…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers [Phase 1, Phase 2]
Phase 1/2 clinical trial update assessing safety, pharmacokinetics and biodistribution of the radiotracer 18F-OP-801 in ALS, Parkinson's dis…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Expression of PARP-1 in Multiple Sclerosis Patients [NA]
This clinical trial update indicates the study on PARP-1 expression in patients with Multiple Sclerosis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Multiple Sclerosis and Overactive Bladder Treatment [NA]
ClinicalTrials.gov entry indicates completion of a study addressing multiple sclerosis–related neurogenic/overactive bladder.
-
EMA withdrawal · 2025-04-30EMA Withdrawn: Extavia (interferon beta-1b) — Novartis Europharm Limited
The European Medicines Agency has withdrawn Extavia (interferon beta-1b) for multiple sclerosis, with Novartis Europharm Limited as the mark…
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: Laughter Yoga for Improving Sexual Function and Psychosocial Outcomes in Multiple Sclerosis [NA]
This clinical trial update reports the completion of a study evaluating laughter yoga as an intervention to improve sexual function and psyc…
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis [Phase 1]
Phase 1 trial of IDP-023 g-NK cells plus ocrelizumab for progressive multiple sclerosis has been suspended.
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: A Study of Suboptimally Controlled Participants Previously Taking Injectable DMDs for RMS (CLICK-MS)
This clinical trial update reports the completion and posted results of CLICK-MS, a study evaluating suboptimally controlled participants wi…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Upper Limb Function in Mental Health Disorders
A completed clinical trial update examining upper limb function in individuals with mental health disorders and multiple sclerosis.
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Effect of Dual-Task Training and Cognitive Rehabilitation in Individuals With Multiple Sclerosis. [NA]
A clinical trial entry indicating recruitment for a study on dual-task training and cognitive rehabilitation in individuals with multiple sc…
-
FDA approval · 2025-04-28FDA Approved: FINGOLIMOD — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for fingolimod submitted by Zydus Lifesciences Limited (ANDA 207994).
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Epidural Stimulation in Multiple Sclerosis [NA]
Clinical trial results indicate that the epidural stimulation study in multiple sclerosis has completed and posted results. The results were…
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Optimizing Detection and Prediction of Changes in Cognitive Function in Multiple Sclerosis (MS)
This clinical trial update describes an ongoing University of Michigan study aimed at improving detection and prediction of cognitive change…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients
A Yale University trial is evaluating immune responses to COVID-19 vaccination in immunodeficient patients, including those with Multiple Sc…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Kinetics, Biodistribution and Repeatability of 11C-BMS-986196 After Intravenous (IV) Administration in Healthy Participants and After Repeat IV Administration in Participants With Multiple Sclerosis [Phase 1]
A Phase 1 study evaluating the safety, tolerability, kinetics, biodistribution, and repeatability of the radiotracer 11C-BMS-986196 after IV…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Genes and Environment in Multiple Sclerosis
A Columbia University-sponsored study investigating the roles of genetic and environmental factors in multiple sclerosis is currently recrui…
-
CLINICAL_TRIALS trial_result · 2025-04-23Clinical Trial Update: A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.
This completed clinical trial from the Swiss Multiple Sclerosis Cohort evaluated whether disease-modifying therapies affect COVID-19 outcome…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Macromolecular Imaging of White and Gray Matter Pathology in Multiple Sclerosis
This entry reports on a University of Wisconsin, Madison–led clinical trial investigating macromolecular imaging of white and gray matter pa…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Smart Monitoring Assessing Spasticity-related Health
A clinical trial sponsored by Heinrich-Heine University in Düsseldorf is evaluating smart monitoring to assess spasticity-related health in …
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Impact of Direct Current Electrical Stimulation on Spasticity Levels and Functional Muscle Use in MS [NA]
This completed clinical trial evaluated direct current electrical stimulation for reducing spasticity and improving functional muscle use in…
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Reliability of Kinovea in Gait Assessment in Multiple Sclerosis: a Pilot Study.
This completed pilot study evaluates the reliability of Kinovea, a video analysis tool, for gait assessment in individuals with multiple scl…
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Proximal Resistance Training for People With Multiple Sclerosis [NA]
Clinical trial update indicates the proximal resistance training study for people with Multiple Sclerosis has completed. The snippet provide…
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Prospective Stratification of Infectious Risks in Multiple Sclerosis
Completed clinical trial investigating prospective stratification of infectious risks in people with multiple sclerosis. The update indicate…